Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.07
0.943 %
$ 9.5 M
Market Cap
0.92
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
41.78%
EBIT
Estimate
--26.17%
Net Income
Estimate
27.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biofrontera Inc.
BFRI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BFRI
EBIT FORECAST
EBIT Forecast Chart BFRI
NET INCOME FORECAST
Net Income Chart BFRI